Latest filing published 05 Jan 2026 for Progyny, Inc., €47k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
David J. Schlanger, listed as chief executive, appears in our data through filings on Progyny, Inc. shares, published by SEC (Form 4). The record holds 71 filings, for trades running from 3 May 2021 to 2 January 2026.
On the open market, the record shows 1 purchase worth €2.1M and 2 sales worth €5.3M. Taken together, the sales exceed the purchases by €3.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 13 share grants and 55 option exercises.
The newest entry dates from 5 January 2026: a share grant of €47k, in Progyny, Inc. The last purchase on record was published on 26 December 2024, which is 661 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 71 declarations